Gilead Sciences



Ebit تغيير تاريخ
AbbVie USD 5.24B 1.5B 2024-12
Agios Pharmaceuticals USD -125037000 22.23M 2024-12
ALKERMES USD 162.69M 46.46M 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 4.03B 11M 2024-12
Biogen USD 644.1M 100.9M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Eli Lilly USD 3.7B 1.93B 2025-03
Gilead Sciences USD 2.89B 221M 2025-03
GlaxoSmithKline GBP 2.53B 1.1B 2025-03
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Incyte USD 283.64M 92.62M 2025-03
J&J USD 7.39B 2.04B 2025-03
Merck USD 5.22B 339M 2024-12
Moderna USD -963000000 283M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 5.93B 1.31B 2025-03
PTC Therapeutics USD -162389000 107.88M 2024-12
Regeneron Pharmaceuticals USD 913.7M 661M 2025-03
Sanofi EUR 2.9B 824M 2025-03
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
United Therapeutics USD 382.8M 25.1M 2025-03
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Gilead Sciences - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.